Find a Doctor or Practice Location

You can also search for providers and practices at Penn Medicine Lancaster General Health or Princeton Health.

I am searching for a
Reset Form
Kim A. Reiss Binder, MD

Kim A. Reiss Binder, MD Physician

Assistant Program Director of the Hematology/Oncology Fellowship Program Emeritus Professor CE of Medicine

Languages spoken:

  • Dutch

Dr. Reiss Binder is employed by Penn Medicine.

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Clinical Specialties


  • Medical Oncology

Programs & Centers:

Board Certification:

  • Internal Medicine, 2011
  • Medical Oncology, 2016

Clinical Expertise:

  • Abdominal Chemotherapy
  • Anal Cancer
  • Anorectal Cancer
  • Appendix Cancer
  • Biological Targeted Therapy
  • Cancer Chemotherapy
  • Carcinoid of the Stomach
  • Carcinoid Tumor of Pancreas
  • Carcinoid Tumors
  • Colon Cancer Chemotherapy
  • Colorectal Cancer
  • Cystadenoma of Pancreas
  • Esophageal Cancer
  • Esophagogastric Junction Cancer
  • Gallbladder Cancer
  • Gallbladder Mass
  • Gastrointestinal Stromal Tumors (GIST)
  • Hepatobiliary Malignancies
  • Hereditary Colon Cancer
  • Hereditary Nonpolyposis Colorectal Cancer
  • Immunotherapy
  • Insulinoma
  • Liver Cancer
  • Malignant Neoplasm of Pancreatic Duct
  • Malignant Tumor of Extrahepatic Bile Duct
  • Neuroendocrine Tumors
  • Pseudomyxoma Peritonei
  • Small Bowel Cancer
  • Small Intestine Cancer
  • Squamous Cell Carcinoma of the Esophagus
Show All Expertise

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Amerihealth Caritas
  • Amerihealth Caritas Medicare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oscar Health Plan of PA
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: Pennsylvania State University College of Medicine
Residency: Johns Hopkins Hospital
Fellowship: Johns Hopkins Hospital


American Society of Clinical Oncology, National ECOG-ACRIN, National FDA Advisory Committee, National FORCE: Facing Our Risk of Cancer Empowered, National PANCAN Precision Promise, National PANCAN Precision Promise, National PARP Inhibitor in Gastrointestinal Malignancies Working Group, National

Hospital Affiliation

Dr. Reiss Binder is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.


Selected Publications:

Max Wattenberg, Daniella Asch, Shun Yu, Peter O’Dwyer, Susan Domchek, Katherine Nathanson, Mark Rosen, Gregory L Beatty, Evan Siegelman, and Kim Reiss: Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation British Journal of Cancer : 2019.

Ofer Margalit, Ronac Mamtani, Yaacov Lawrence, Yu-Xiao Yang, Bruce Giantonio, Talia Golan, Dan Aderka, Naama Halpern, Kim Reiss, Einat Shacham-Shmueli, Ben Boursi: Post-Operative Radiation for Pathologic Stage T4 Colon Cancers Receiving Adjuvant Chemotherapy Clinical Colorectal Cancer : 2019.

Ben Boursi, Bruce Giantonio, Dan Aderka, Einat Shacham-Shmueli, Kim Reiss, Naama Halpern, Ofer Margalit, Raashi Mamtani, Talia Golan, Yu-Xiao Yang, Yaacov Lawrence: Lung Metastasis Predicts Better Prognosis in Metastatic Colorectal Cancer with Mutated KRAS Clinical Colorectal Cancer : 2019.

Erin Bange, Abigail Doucette, Peter Gabriel, Robin Wang, Andrzej P Wojcieszynski, Bethany Mooney, Ben Boursi, Kim Anna Reiss, Ronac Mamtani: Opportunity Costs of Receiving Palliative Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma(mPDAC) International Conference on Pharmacoepidemiology and Therapeutic Risk Management : 2019.

Kim A. Reiss, MD; Rosemarie Mick, MS; Mark O’Hara, MD; Ursina Teitelbaum, MD; Thomas Karasic, MD; Charles Schneider, MD; Peter O’Dwyer, MD; Danielle Karlson, RN; Stacy Cowden, RN; Mary Jane Fuhrer, BA; Erica Carpenter, PhD; Austin Pantel, MD; Mehran Makvandi, PharmD; David Mankoff, MD, PhD; Katharine Nathanson, MD; Kara Maxwell, MD, PhD; Gregory Beatty, MD, PhD; Susan Domchek, MD: A Randomized Phase II Trial of Niraparib Plus Either Nivolumab or Ipilimumab in Patients with Platinum Sensitive, Advanced Pancreatic Cancer ASCO Annual Meeting, Chicago, IL : 2019.

Margalit O, Mamtani R, Lawrence YR, Yang YX, Baruch EN, Reiss KA, Golan T, Halpern N, Aderka D, Giantonio B, Shacham-Shmueli E, Boursi B.: Locally advanced rectal adenocarcinoma: Are preoperative short and long course radiotherapy truly equivalent? Molecular and Clinical Oncology : 2019.

Thomas B. Karasic, MD; Mark O'Hara, MD; Arturo Loaiza-Bonilla, MD; Kim A. Reiss, MD; Ursina R. Teitelbaum, MD; Erkut Borazanci, MD; Ana De Jesus-Acosta, MD; Colleen Redlinger, BA; Jessica A. Burrell, BA; Daniel A. Laheru, MD; Daniel D. Von Hoff, MD; Ravi K. Amaravadi, MD; Jeffrey A. Drebin, MD, PhD; Peter J. O’Dwyer, MD: Randomized Phase II Trial of Gemcitabine and 'nab-Paclitaxel With or Without Hydroxychloroquine in Advanced Pancreatic Cancer JAMA Oncology : 2019.

Stéphanie L. Gaillard, MD, PhD; Marianna Zahurak; Anup Sharma; Kim Reiss, MD; Susan Sartorius; Melinda Downs; Nicole M. Anders; Nita Ahuja, MD; Michelle A. Rudek, PhD1; Nilofer Azad, MD: A phase I trial of oral DNA methyltransferase inhibitor CC-486 and the histone deacetylase inhibitor romidepsin in advanced solid tumors Cancer : 2019.

Shivaani Kummar, Shuli Li, Kim A Reiss, James M Ford, Edith P. Mitchell, Lisa M. McShane, Robert J. Gray, Larry V. Rubinstein, David Patton, P. Mickey Williams, Stanley R. Hamilton, Barbara A. Conley, Peter J. O'Dwyer, Lyndsay N. Harris, Carlos L. Arteaga, Alice P. Chen, Keith T. Flaherty: NCI-MATCH EAY131 –Z1I: Phase II Study of AZD1775, a Wee-1 kinase inhibitor, in Patients with Tumors Containing BRCA1 and BRCA2 Mutations AACR Annual Meeting, Atlanta, GA : 2019.

Brittany Bauman, Rosemarie Mick, Eileen Martinez, Theresa Lawless, Lindsey Zinck, Paige Madison, Mary Fuhrer, Mark O’Hara, Charles Schneider, Peter O’Dwyer, John Plastaras, Ursina Teitelbaum, and Kim A. Reiss: Efficacy of oral cryotherapy during oxaliplatin infusion in preventing oral thermal hyperalgesia: A randomized trial JNCCN : 2019.

Academic Contact Info

Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-305
3400 Civic Center Blvd

Philadelphia, PA 19104
Phone: (215) 360-0735
Patient appointments: 800-789-7366